中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共1条，第1-1条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2022, 卷号: 23
作者:  Zhou, Qing;  Chen, Ming;  Jiang, Ou;  Pan, Yi;  Hu, Desheng;  Lin, Qin;  Wu, Gang;  Cui, Jiuwei;  Chang, Jianhua;  Cheng, Yufeng;  Huang, Cheng;  Liu, Anwen;  Yang, Nong;  Gong, Youling;  Zhu, Chuan;  Ma, Zhiyong;  Fang, Jian;  Chen, Gongyan;  Zhao, Jun;  Shi, Anhui;  Lin, Yingcheng;  Li, Guanghui;  Liu, Yunpeng;  Wang, Dong;  Wu, Rong;  Xu, Xinhua;  Shi, Jianhua;  Liu, Zhihua;  Cui, Na;  Wang, Jingru;  Wang, Qiang;  Zhang, Ran;  Yang, Jason;  Wu, Yi-Long
收藏  |  浏览/下载：71/0  |  提交时间：2022/03/21